20:25:45 EDT Thu 18 Apr 2024
Enter Symbol
or Name
USA
CA



Blissco Cannabis Corp
Symbol BLIS
Shares Issued 99,594,338
Close 2018-05-22 C$ 0.37
Market Cap C$ 36,849,905
Recent Sedar Documents

Blissco Cannabis receives HC inspection date

2018-05-23 06:50 ET - News Release

Mr. Damian Kettlewell reports

BLISSCO CANNABIS CORP PROVIDES CORPORATE UPDATE

Blissco Cannabis Corp. has provided a corporate update on the company's wholly owned subsidiary, Bliss Co Holdings Ltd.

"We are seeing tremendous momentum and interest as we continue to expand our team and put all the pieces into place for a successful product launch once our sales licence is approved," said Damian Kettlewell, chief executive officer of Blissco Cannabis.

Bliss Co has:

  • Been featured in over 100 articles nationwide discussing the byproduct of cannabis production, its proper disposal and its future opportunities;
  • Received an invitation to participate in a live interview with Midas Letter in Toronto on May 24 at 11:30 a.m. Eastern Standard Time;
  • Made key hires including:
    • Quality assurance team: Sheena Leung:
      • Ms. Leung's extensive pharmaceutical and food production QAP (quality assurance program) management experience will position Bliss Co well as the company looks to earn approval from Health Canada for new and innovative medical and adult use cannabis products;
    • Branding and packaging: enlisted an award-winning Vancouver design agency specializing in branding, packaging design for health, food, fashion and lifestyle brands;
  • Purchased oil production machinery that uses carbon dioxide, producing higher-quality product for medical customers and sets Bliss Co up to maintain the quality of byproducts for when their use is legal:
    • "Selecting CO2 over other methods and processes can save and separate much more byproduct from the extraction process. Given where legalization is going, we want to be ready with an array of potential products outside the traditional methods of consuming cannabis or derivatives via sublingual, combustion or vaporization," said Shawn McDougal, production manager, Bliss Co;
  • Remains on track to secure sales licence in September;
  • Expanded supplier relationships for both medical and recreational product;
  • Secured an inspection date from Health Canada for May 28 to May 31.

"We are pleased with the progress that we have seen in the past several weeks. Our six varieties of premium cultivars have adapted well to their new home. We are excited for our continued expansion and are well on our way to obtaining our sales licence in September, at which point we will be set up and able to begin sales immediately," said Mr. Kettlewell.

About Blissco Cannabis Corp.

Blissco earned its Access to Cannabis for Medical Purposes Regulation (ACMPR) licence to cultivate on Thursday, March 29, 2018. Blissco's ACMPR facility in Langley, B.C., is designed to be a high-volume packager, processor and distributor of medical cannabis and adult use cannabis when it is legal in Canada, which is currently anticipated to be by August, 2018, at the earliest. Blissco has a two-year supply agreement with the Supreme Cannabis Company Inc. to purchase premium dried cannabis curated over the last two years from imported cannabis seeds.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.